Literature DB >> 2901203

Solid-phase extraction and ion-pair reversed-phase HPLC of isometamidium in bovine serum and tissues.

L D Kinabo1, J A Bogan.   

Abstract

An analytical method has been developed for the determination of isometamidium in bovine serum and tissues. Samples were enzymatically hydrolysed and cleaned up on a solid-phase system (C8 Bond Elut column). The drug was chromatographed by an ion-pair reversed-phase technique using heptane sulphonate as a pairing-ion and triethylamine as a counter-ion reagent. Detection was by fluorescence at 593 nm (excitation = 380 nm). The method is more sensitive and specific than existing methods and it is currently being used in evaluating the pharmacokinetics of isometamidium in cattle.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2901203

Source DB:  PubMed          Journal:  Acta Trop        ISSN: 0001-706X            Impact factor:   3.112


  5 in total

Review 1.  Current models in pharmacokinetics: applications in veterinary pharmacology.

Authors:  L D Kinabo; Q A McKellar
Journal:  Vet Res Commun       Date:  1989       Impact factor: 2.459

2.  Development of a radioimmunoassay for isometamidium.

Authors:  L D Kinabo; J A Bogan
Journal:  Vet Res Commun       Date:  1988       Impact factor: 2.459

3.  Therapeutic activity of isometamidium chloride in Boran cattle against a tsetse-transmitted clone of Trypanosoma congolense with a low level of drug resistance.

Authors:  I A Sutherland; V Codjia; S K Moloo; P H Holmes; A S Peregrine
Journal:  Trop Anim Health Prod       Date:  1992-08       Impact factor: 1.559

4.  Feeder layer-free in vitro assay for screening antitrypanosomal compounds against Trypanosoma brucei brucei and T. b. evansi.

Authors:  R Kaminsky; E Zweygarth
Journal:  Antimicrob Agents Chemother       Date:  1989-06       Impact factor: 5.191

5.  The accumulation and compartmentalization of isometamidium chloride in Trypanosoma congolense, monitored by its intrinsic fluorescence.

Authors:  J M Wilkes; A S Peregrine; D Zilberstein
Journal:  Biochem J       Date:  1995-11-15       Impact factor: 3.857

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.